Bicycle Therapeutics (BCYC) Enterprise Value (2018 - 2025)
Bicycle Therapeutics (BCYC) has disclosed Enterprise Value for 8 consecutive years, with -$648.3 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Enterprise Value rose 27.22% year-over-year to -$648.3 million, compared with a TTM value of -$648.3 million through Sep 2025, up 27.22%, and an annual FY2024 reading of -$879.5 million, down 67.07% over the prior year.
- Enterprise Value was -$648.3 million for Q3 2025 at Bicycle Therapeutics, up from -$721.5 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$195.9 million in Q1 2021 and bottomed at -$961.4 million in Q2 2024.
- Average Enterprise Value over 5 years is -$541.2 million, with a median of -$457.0 million recorded in 2024.
- The sharpest move saw Enterprise Value rose 27.88% in 2023, then tumbled 182.39% in 2024.
- Year by year, Enterprise Value stood at -$438.7 million in 2021, then increased by 22.69% to -$339.2 million in 2022, then crashed by 55.22% to -$526.4 million in 2023, then crashed by 67.07% to -$879.5 million in 2024, then rose by 26.29% to -$648.3 million in 2025.
- Business Quant data shows Enterprise Value for BCYC at -$648.3 million in Q3 2025, -$721.5 million in Q2 2025, and -$793.0 million in Q1 2025.